Dyno Therapeutics, Inc.
20 Marks
Corp.
First Filed:May 15, 2018Latest Filed:Jul 10, 2026Address:343 Arsenal Street, Watertown, MA 02472, US
Portfolio Overview
Top Classes
Class 45
Personal servicesClass 5
PharmaceuticalsClass 42
Software, IT Services & Scientific ResearchTTAB Proceedings
No litigation activity
Top Firms
Loading...
Trademark Activity Timeline(2018 – 2026)
Trademark Portfolio
20 results
(current & previous marks)
Refine by Mark/Description🔽
Filed
Registered
Last Activity
Filters
Ownership
20
0
Status
4
15
0
1
0
Mark Type
15
0
2
3
0
TTAB
0
0
20
7
3
7
3
11
Description: Class 35: Association services, namely, promoting the interests of gene therapy developers, manufacturers, and research organizations in the fields of genetic medicine, gene therapy, gene delivery, viral capsid technology, and biomanufacturing for gene therapy and gene delivery applications; business networking services in the fields of genetic medicine, gene therapy, gene delivery, viral capsid technology, and biomanufacturing for gene therapy and gene delivery applications; facilitating business connections and collaboration among organizations engaged in gene therapy development, gene delivery, viral capsid technology, and biomanufacturing for gene therapy and gene delivery applications; administration of a business network in the fields of genetic medicine, gene therapy, gene delivery, and viral capsid technology
Class 42: Consulting services in the fields of biotechnology, pharmaceutical research and development, genetic science, gene therapy, gene delivery, and viral capsid technology; scientific research and development in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, viral capsid technology, genetic engineering, gene therapeutics, and research tools; biotechnology research services; research and development of new products in the field of gene therapeutics and research tools; providing a collaborative technology network for researchers and organizations in the fields of gene therapy, gene delivery, and viral capsid technology; facilitating scientific collaboration among gene therapy developers, manufacturers, and research organizations in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; providing access to proprietary capsid technologies for use in gene therapy and gene delivery research and development; data sharing services in the fields of biotechnology, gene therapy, and viral capsid technology, namely, coordinating the exchange of scientific and technical data among network participants
Class 45: Licensing of intellectual property, namely, licensing of gene therapy capsid technology to network participants; licensing of protein and nucleic acid sequences and methods of use in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; intellectual property licensing services in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; technology transfer services, namely, licensing and transfer of intellectual property in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; administration of licensing programs in the fields of gene therapy and viral capsid technologies
Class 42: Consulting services in the fields of biotechnology, pharmaceutical research and development, genetic science, gene therapy, gene delivery, and viral capsid technology; scientific research and development in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, viral capsid technology, genetic engineering, gene therapeutics, and research tools; biotechnology research services; research and development of new products in the field of gene therapeutics and research tools; providing a collaborative technology network for researchers and organizations in the fields of gene therapy, gene delivery, and viral capsid technology; facilitating scientific collaboration among gene therapy developers, manufacturers, and research organizations in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; providing access to proprietary capsid technologies for use in gene therapy and gene delivery research and development; data sharing services in the fields of biotechnology, gene therapy, and viral capsid technology, namely, coordinating the exchange of scientific and technical data among network participants
Class 45: Licensing of intellectual property, namely, licensing of gene therapy capsid technology to network participants; licensing of protein and nucleic acid sequences and methods of use in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; intellectual property licensing services in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; technology transfer services, namely, licensing and transfer of intellectual property in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; administration of licensing programs in the fields of gene therapy and viral capsid technologies
Description: Class 35: Association services, namely, promoting the interests of gene therapy developers, manufacturers, and research organizations in the fields of genetic medicine, gene therapy, gene delivery, viral capsid technology, and biomanufacturing for gene therapy and gene delivery applications; business networking services in the fields of genetic medicine, gene therapy, gene delivery, viral capsid technology, and biomanufacturing for gene therapy and gene delivery applications; facilitating business connections and collaboration among organizations engaged in gene therapy development, gene delivery, viral capsid technology, and biomanufacturing for gene therapy and gene delivery applications; administration of a business network in the fields of genetic medicine, gene therapy, gene delivery, and viral capsid technology
Class 42: Consulting services in the fields of biotechnology, pharmaceutical research and development, genetic science, gene therapy, gene delivery, and viral capsid technology; scientific research and development in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, viral capsid technology, genetic engineering, gene therapeutics, and research tools; biotechnology research services; research and development of new products in the field of gene therapeutics and research tools; providing a collaborative technology network for researchers and organizations in the fields of gene therapy, gene delivery, and viral capsid technology; facilitating scientific collaboration among gene therapy developers, manufacturers, and research organizations in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; providing access to proprietary capsid technologies for use in gene therapy and gene delivery research and development; data sharing services in the fields of biotechnology, gene therapy, and viral capsid technology, namely, coordinating the exchange of scientific and technical data among network participants
Class 45: Licensing of intellectual property, namely, licensing of gene therapy capsid technology to network participants; licensing of protein and nucleic acid sequences and methods of use in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; intellectual property licensing services in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; technology transfer services, namely, licensing and transfer of intellectual property in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; administration of licensing programs in the fields of gene therapy and viral capsid technologies
Class 42: Consulting services in the fields of biotechnology, pharmaceutical research and development, genetic science, gene therapy, gene delivery, and viral capsid technology; scientific research and development in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, viral capsid technology, genetic engineering, gene therapeutics, and research tools; biotechnology research services; research and development of new products in the field of gene therapeutics and research tools; providing a collaborative technology network for researchers and organizations in the fields of gene therapy, gene delivery, and viral capsid technology; facilitating scientific collaboration among gene therapy developers, manufacturers, and research organizations in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; providing access to proprietary capsid technologies for use in gene therapy and gene delivery research and development; data sharing services in the fields of biotechnology, gene therapy, and viral capsid technology, namely, coordinating the exchange of scientific and technical data among network participants
Class 45: Licensing of intellectual property, namely, licensing of gene therapy capsid technology to network participants; licensing of protein and nucleic acid sequences and methods of use in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; intellectual property licensing services in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; technology transfer services, namely, licensing and transfer of intellectual property in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; administration of licensing programs in the fields of gene therapy and viral capsid technologies
Description: Class 35: Association services, namely, promoting the interests of gene therapy developers, manufacturers, and research organizations in the fields of genetic medicine, gene therapy, gene delivery, viral capsid technology, and biomanufacturing for gene therapy and gene delivery applications; business networking services in the fields of genetic medicine, gene therapy, gene delivery, viral capsid technology, and biomanufacturing for gene therapy and gene delivery applications; facilitating business connections and collaboration among organizations engaged in gene therapy development, gene delivery, viral capsid technology, and biomanufacturing for gene therapy and gene delivery applications; administration of a business network in the fields of genetic medicine, gene therapy, gene delivery, and viral capsid technology
Class 42: Consulting services in the fields of biotechnology, pharmaceutical research and development, genetic science, gene therapy, gene delivery, and viral capsid technology; scientific research and development in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, viral capsid technology, genetic engineering, gene therapeutics, and research tools; biotechnology research services; research and development of new products in the field of gene therapeutics and research tools; providing a collaborative technology network for researchers and organizations in the fields of gene therapy, gene delivery, and viral capsid technology; facilitating scientific collaboration among gene therapy developers, manufacturers, and research organizations in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; providing access to proprietary capsid technologies for use in gene therapy and gene delivery research and development; data sharing services in the fields of biotechnology, gene therapy, and viral capsid technology, namely, coordinating the exchange of scientific and technical data among network participants
Class 45: Licensing of intellectual property, namely, licensing of gene therapy capsid technology to network participants; licensing of protein and nucleic acid sequences and methods of use in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; intellectual property licensing services in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; technology transfer services, namely, licensing and transfer of intellectual property in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; administration of licensing programs in the fields of gene therapy and viral capsid technologies
Class 42: Consulting services in the fields of biotechnology, pharmaceutical research and development, genetic science, gene therapy, gene delivery, and viral capsid technology; scientific research and development in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, viral capsid technology, genetic engineering, gene therapeutics, and research tools; biotechnology research services; research and development of new products in the field of gene therapeutics and research tools; providing a collaborative technology network for researchers and organizations in the fields of gene therapy, gene delivery, and viral capsid technology; facilitating scientific collaboration among gene therapy developers, manufacturers, and research organizations in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; providing access to proprietary capsid technologies for use in gene therapy and gene delivery research and development; data sharing services in the fields of biotechnology, gene therapy, and viral capsid technology, namely, coordinating the exchange of scientific and technical data among network participants
Class 45: Licensing of intellectual property, namely, licensing of gene therapy capsid technology to network participants; licensing of protein and nucleic acid sequences and methods of use in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; intellectual property licensing services in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; technology transfer services, namely, licensing and transfer of intellectual property in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; administration of licensing programs in the fields of gene therapy and viral capsid technologies
Description: Licensing of pharmaceutical preparations; licensing of pharmaceutical methods; licensing of protein and nucleic acid sequences and methods of use; Technology transfer services, namely, licensing and transfer of intellectual property; Medical services; Medical services, namely, genetic engineering and gene therapy services; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Custom development of biochemical reagents, namely, synthesis for others of clinical medical reagents for use in gene therapy, development of pharmaceutical preparations for use in gene therapy; Development of products being genetic therapies; scientific research in the field of genetic engineering, biotechnology research services, and research and development of new products in the field of gene therapeutics and research tools; Research and development in the pharmaceutical and biotechnology fields; Scientific and medical research and development; Scientific research and product development services for others in the pharmaceutical, biotechnology, medical and agriculture fields; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
Description: Class 42: Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Custom development of biochemical reagents, namely, synthesis for others of clinical medical reagents for use in gene therapy, development of pharmaceutical preparations for use in gene therapy; Development of products being genetic therapies; scientific research in the field of genetic engineering, biotechnology research services, and research and development of new products in the field of gene therapeutics and research tools; Research and development in the pharmaceutical and biotechnology fields; Scientific and medical research and development; Scientific research and product development services for others in the pharmaceutical, biotechnology, medical and agriculture fields; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
Class 45: Licensing of pharmaceutical preparations; licensing of pharmaceutical methods; licensing of protein and nucleic acid sequences and methods of use; Technology transfer services, namely, licensing and transfer of intellectual property
Class 45: Licensing of pharmaceutical preparations; licensing of pharmaceutical methods; licensing of protein and nucleic acid sequences and methods of use; Technology transfer services, namely, licensing and transfer of intellectual property
Description: Pharmaceutical preparations and therapeutic agents for use in gene therapy; pharmaceutical preparations containing adeno-associated virus (AAV) protein sequences and nucleic acid sequences for use in gene delivery; Gene therapy pharmaceutical preparations; pharmaceutical preparations for gene therapy for the treatment of genetic diseases or disorders; pharmaceutical preparations for use in the treatment of gene therapy treatable diseases
Description: Class 42: Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Custom development of biochemical reagents, namely, synthesis for others of clinical medical reagents for use in gene therapy, development of pharmaceutical preparations for use in gene therapy; Development of products being genetic therapies; scientific research in the field of genetic engineering, biotechnology research services, and research and development of new products in the field of gene therapeutics and research tools; Research and development in the pharmaceutical and biotechnology fields; Scientific and medical research and development; Scientific research and product development services for others in the pharmaceutical, biotechnology, medical and agriculture fields; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
Class 45: Licensing of pharmaceutical preparations; licensing of pharmaceutical methods; licensing of protein and nucleic acid sequences and methods of use; Technology transfer services, namely, licensing and transfer of intellectual property
Class 45: Licensing of pharmaceutical preparations; licensing of pharmaceutical methods; licensing of protein and nucleic acid sequences and methods of use; Technology transfer services, namely, licensing and transfer of intellectual property
Description: Licensing of pharmaceutical preparations; licensing of pharmaceutical methods; licensing of protein and nucleic acid sequences and methods of use; Technology transfer services, namely, licensing and transfer of intellectual property; Medical services; Medical services, namely, genetic engineering and gene therapy services; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Custom development of biochemical reagents, namely, synthesis for others of clinical medical reagents for use in gene therapy, development of pharmaceutical preparations for use in gene therapy; Development of products being genetic therapies; scientific research in the field of genetic engineering, biotechnology research services, and research and development of new products in the field of gene therapeutics and research tools; Research and development in the pharmaceutical and biotechnology fields; Scientific and medical research and development; Scientific research and product development services for others in the pharmaceutical, biotechnology, medical and agriculture fields; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
Description: Pharmaceutical preparations and therapeutic agents for use in gene therapy; pharmaceutical preparations containing adeno-associated virus (AAV) protein sequences and nucleic acid sequences for use in gene delivery; Gene therapy pharmaceutical preparations; pharmaceutical preparations for gene therapy for the treatment of genetic diseases or disorders; pharmaceutical preparations for use in the treatment of gene therapy treatable diseases; pharmaceutical preparations ,namely, therapeutic pharmaceuticals in the nature of non-natural and synthetic adeno-associated virus (AAV) protein sequences and nucleic acid sequences for the treatment of gene therapy treatable diseases; Pharmaceutical preparations in the nature of genetically modified cells for use in the production of pharmaceutical preparations and products, for use in gene therapy for medical purposes; Drug delivery agents in the form of viral vectors comprised of non-natural and synthetic adeno-associated virus (AAV) protein sequences and nucleic acid sequences for medical and pharmaceutical purposes; Pharmaceutical preparations for scientific research and pharmaceutical research for the treatment and prevention of gene therapy treatable diseases
Description: Pharmaceutical preparations and therapeutic agents for use in gene therapy; pharmaceutical preparations containing adeno-associated virus (AAV) protein sequences and nucleic acid sequences for use in gene delivery; Gene therapy pharmaceutical preparations; pharmaceutical preparations for gene therapy for the treatment of genetic diseases or disorders; pharmaceutical preparations for use in the treatment of gene therapy treatable diseases; pharmaceutical preparations, namely, therapeutic pharmaceuticals in the nature of non-natural and synthetic adeno-associated virus (AAV) protein sequences and nucleic acid sequences for the treatment of gene therapy treatable diseases; Pharmaceutical preparations in the nature of genetically modified cells for use in the production of pharmaceutical preparations and products, for use in gene therapy for medical purposes; Drug delivery agents in the form of viral vectors comprised of non-natural and synthetic adeno-associated virus (AAV) protein sequences and nucleic acid sequences for medical and pharmaceutical purposes; Pharmaceutical preparations for scientific research and pharmaceutical research for the treatment and prevention of gene therapy treatable diseases
Description: Pharmaceutical preparations and therapeutic agents for use in gene therapy; pharmaceutical preparations containing adeno-associated virus (AAV) protein sequences and nucleic acid sequences for use in gene delivery; Gene therapy pharmaceutical preparations; pharmaceutical preparations for gene therapy for the treatment of genetic diseases or disorders; pharmaceutical preparations for use in the treatment of gene therapy treatable diseases; pharmaceutical preparations, namely, therapeutic pharmaceuticals in the nature of non-natural and synthetic adeno-associated virus (AAV) protein sequences and nucleic acid sequences for the treatment of gene therapy treatable diseases; Pharmaceutical preparations in the nature of genetically modified cells for use in the production of pharmaceutical preparations and products, for use in gene therapy for medical purposes; Drug delivery agents in the form of viral vectors comprised of non-natural and synthetic adeno-associated virus (AAV) protein sequences and nucleic acid sequences for medical and pharmaceutical purposes; Pharmaceutical preparations for scientific research and pharmaceutical research for the treatment and prevention of gene therapy treatable diseases
Description: Pharmaceutical preparations and therapeutic agents for use in gene therapy; pharmaceutical preparations containing adeno-associated virus (AAV) protein sequences and nucleic acid sequences for use in gene delivery; Gene therapy pharmaceutical preparations; pharmaceutical preparations for gene therapy for the treatment of genetic diseases or disorders; pharmaceutical preparations for use in the treatment of gene therapy treatable diseases; pharmaceutical preparations, namely, therapeutic pharmaceuticals in the nature of non-natural and synthetic adeno-associated virus (AAV) protein sequences and nucleic acid sequences for the treatment of gene therapy treatable diseases; Pharmaceutical preparations in the nature of genetically modified cells for use in the production of pharmaceutical preparations and products, for use in gene therapy for medical purposes; Drug delivery agents in the form of viral vectors comprised of non-natural and synthetic adeno-associated virus (AAV) protein sequences and nucleic acid sequences for medical and pharmaceutical purposes; Pharmaceutical preparations for scientific research and pharmaceutical research for the treatment and prevention of gene therapy treatable diseases
Description: Class 42: Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Custom development of biochemical reagents, namely, synthesis for others of clinical medical reagents for use in gene therapy, development of pharmaceutical preparations for use in gene therapy; Development of products being genetic therapies; scientific research in the field of genetic engineering, biotechnology research services, and research and development of new products in the field of gene therapeutics and research tools; Research and development in the pharmaceutical and biotechnology fields; Scientific and medical research and development; Scientific research and product development services for others in the pharmaceutical, biotechnology, medical and agriculture fields; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
Class 45: Licensing of pharmaceutical preparations; licensing of pharmaceutical methods; licensing of protein and nucleic acid sequences and methods of use; Technology transfer services, namely, licensing and transfer of intellectual property
Class 45: Licensing of pharmaceutical preparations; licensing of pharmaceutical methods; licensing of protein and nucleic acid sequences and methods of use; Technology transfer services, namely, licensing and transfer of intellectual property
Description: Pharmaceutical preparations and therapeutic agents for use in gene therapy; pharmaceutical preparations containing adeno-associated virus (AAV) protein sequences and nucleic acid sequences for use in gene delivery; Gene therapy pharmaceutical preparations; pharmaceutical preparations for gene therapy for the treatment of genetic diseases or disorders; pharmaceutical preparations for use in the treatment of gene therapy treatable diseases; Licensing of pharmaceutical preparations; licensing of pharmaceutical methods; licensing of protein and nucleic acid sequences and methods of use; Technology transfer services, namely, licensing and transfer of intellectual property; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Custom development of biochemical reagents, namely, synthesis for others of clinical medical reagents for use in gene therapy, development of pharmaceutical preparations for use in gene therapy; Development of products being genetic therapies; scientific research in the field of genetic engineering, biotechnology research services, and research and development of new products in the field of gene therapeutics and research tools; Research and development in the pharmaceutical and biotechnology fields; Scientific and medical research and development; Scientific research and product development services for others in the pharmaceutical, biotechnology, medical and agriculture fields; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
Description: Pharmaceutical preparations and therapeutic agents for use in gene therapy; pharmaceutical preparations containing adeno-associated virus (AAV) protein sequences and nucleic acid sequences for use in gene delivery; Gene therapy pharmaceutical preparations; pharmaceutical preparations for gene therapy for the treatment of genetic diseases or disorders; pharmaceutical preparations for use in the treatment of gene therapy treatable diseases
Description: Licensing of pharmaceutical preparations; licensing of pharmaceutical methods; licensing of protein and nucleic acid sequences and methods of use; Technology transfer services, namely, licensing and transfer of intellectual property; Medical services; Medical services, namely, genetic engineering and gene therapy services; "THERAPEUTICS"; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Custom development of biochemical reagents, namely, synthesis for others of clinical medical reagents for use in gene therapy, development of pharmaceutical preparations for use in gene therapy; Development of products being genetic therapies; scientific research in the field of genetic engineering, biotechnology research services, and research and development of new products in the field of gene therapeutics and research tools; Research and development in the pharmaceutical and biotechnology fields; Scientific and medical research and development; Scientific research and product development services for others in the pharmaceutical, biotechnology, medical and agriculture fields; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy